Proteasome Inhibitors Market Industry Analysis, Share, Size, Recent Trends & Demand and Forecast 202 pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Message :
Required fields
Achieved primary endpoint demonstrating significant correlation between DetermaIO and two-year overall survival rate to atezolizumab in metastatic bladder cancer
DetermaIO identified additional immunotherapy responsive patients missed by commonly used biomarkers
Data supports potential utility of DetermaIO test across multiple solid tumors as predictor of response to Immune Checkpoint Inhibitor therapy in estimated $3 billion market in the United States
KOL Webinar discussing results to be held on April 19 at 11:30 AM EDT/8:30 AM PDT
IRVINE, Calif., April 10, 2021 (GLOBE NEWSWIRE) Oncocyte Corporation (Nasdaq: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, presented new data at the American Association for Cancer Research (AACR) Annual Meeting 2021, being held virtually from April 10-15, 2021. The presentations featured studies of Oncocyte’s novel
Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting ... apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Search jobs 12-Mar-2021 Implementation of government regulations will boost the blood cancer drugs market, forecast to touch US$ 41 Bn by 2025 at a CAGR of 6%
Noida, Uttar Pradesh, India, March 12 2021 (Wiredrelease) Report Ocean Pvt Ltd –:The Global Blood Cancer Drugs Market is estimated to see healthy growth, pegged at a CAGR of around 6% throughout the forecast period 2020-2025.
The increasing prevalence of blood cancer cases and the growing death incidence rate worldwide are the main blood cancer drug market drivers. Also, the different blood cancers types such as lymphoma, myeloma, leukemia, and others have various risk factors that can be prevented or controlled through drug therapies, and others may lead to death. According to the 2018 Bristol-Myers Squibb Company report, over 1.85 million new blood cancer cases are expected to be diagnosed globally in 2040, out of which 918,872 cases are from lymph, 656,345 from leukemia, a